The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes after adjuvant anti-PD1 therapy for high-risk resectable melanoma and predictors of response.
 
John Marsiglio
No Relationships to Disclose
 
Feng Bingjian
Honoraria - OncLive (Intellisphere LLC) (I)
Research Funding - Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Regeneron (Inst)
Patents, Royalties, Other Intellectual Property - The PERCH software, for which I am the inventor, has been non-exclusively licensed to Ambry Genetics for their clinical genetic testing service and research.
 
Magdalena Kovacsovics
No Relationships to Disclose
 
Berit Gibson
No Relationships to Disclose
 
Qin Zhou
No Relationships to Disclose
 
Umang Swami
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Exelixis; Gilead Sciences; Imvax; Pfizer; Sanofi; Seagen
Research Funding - Exelixis (Inst); Janssen (Inst); Seattle Genetics/Astellas (Inst)
 
Jeffery Scott Russell
Employment - Janssen
Stock and Other Ownership Interests - Janssen Research & Development
 
Alyssa Erickson-Wayman
No Relationships to Disclose
 
Elliot Amponsah Asare
No Relationships to Disclose
 
Marcus Monroe
No Relationships to Disclose
 
Tawnya Lynn Bowles
Research Funding - Amgen (Inst); Genentech (Inst); MAVIS (Inst); Natera (Inst); Replimune (Inst)
 
David Nix
No Relationships to Disclose
 
Matthew Williams
No Relationships to Disclose
 
Aik-choon Tan
Employment - Bristol-Myers Squibb/Celgene/Juno (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene/Juno (I)
 
John Robert Hyngstrom
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Amgen (Inst); Bristol Myers Squibb Foundation (Inst); Checkmate Pharmaceuticals (Inst); Iovance Biotherapeutics (Inst); Lokon Pharma (Inst); Merck (Inst); Morphogenesis (Inst); oncosec (Inst); Philogen (Inst); Signatera (Inst); Skyline Diagnostics (Inst); Takara Bio (Inst)
 
Siwen Hu-Lieskovan
Consulting or Advisory Role - Amgen; Astellas Pharma; Genmab; Nektar; Regeneron; Xencor